A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea

被引:3
|
作者
Seo, Ji-Hye [1 ]
Kim, Ock-Joo [1 ]
Yoo, Sang-Ho [2 ]
Choi, Eun Kyung [3 ]
Park, Ji-Eun [4 ]
机构
[1] Seoul Natl Univ, Dept Hist Med & Med Humanities, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea
[2] Hanyang Univ, Dept Med Human & Eth, Coll Med, Seoul, South Korea
[3] Korea Natl Inst Bioeth Policy, Seoul, South Korea
[4] Korea Inst Oriental Med, KM Data Div, Daejeon, South Korea
关键词
phase I clinical trials; healthy volunteers; informed consent; research ethics;
D O I
10.1177/15562646211034275
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
The phase I trial is the first step in administering a drug to humans, but it has no therapeutic purpose. Under the absence of therapeutic purpose, healthy volunteers demonstrated different motivations, unlike the actual patients participating in trials. There were many reported motivations, such as financial motivation, contributing to the health science, accessing ancillary health care benefits, scientific interest or interest in the goals of the study, meeting people, and general curiosity. The aim of this study was to identify the motivation and characteristics of healthy volunteers participating in phase I trials in the Republic of Korea. We gave surveys to 121 healthy volunteers to study their demographic characteristics and the reasons of participation. We identified whether the decision to participate in the research was influenced by demographic factors and whether the perception and attitudes toward the research were influenced by the characteristics of the healthy volunteers. After completion of the first survey, 12 healthy volunteers who had participated in a phase I clinical trial were selected to answer the second interview. According to our survey, most healthy volunteers were unmarried men and economically dependent. Most of them participated in the study because of financial reward. The most important factor to measure financial reward was the research period. Also, 43% of the volunteers were university students, 42% answered "university graduation" and 55% were residing in family-owned houses. Many healthy volunteers were found to be living in family homes and to have a student status or lack of economic independence. Results of the survey showed that 64% of respondents indicated having more than one clinical trial participation. In-depth interviews showed that healthy volunteers had diverse motivation to participate in research and that healthy volunteer perceive the clinical trial positively. The main motivation for healthy volunteers' participation in research was "financial reward." Healthy volunteers also considered research schedules, processes, and safety, and had a positive perception of clinical trials, but they thought that the public has a negative perception.
引用
收藏
页码:193 / 212
页数:20
相关论文
共 50 条
  • [11] WEIGHT OF FINANCIAL REWARD IN THE DECISION BY MEDICAL-STUDENTS AND EXPERIENCED HEALTHY-VOLUNTEERS TO PARTICIPATE IN CLINICAL-TRIALS
    BIGORRA, J
    BANOS, JE
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (05) : 443 - 446
  • [12] The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research
    Zejuan Wang
    Gang Chen
    Xiaona Liu
    Chen Liu
    Qingkun Song
    Jin Wang
    European Journal of Clinical Pharmacology, 2021, 77 : 557 - 568
  • [13] Knowledge and willingness to participate in research: a descriptive study of volunteers in a clinical trial
    Lobato, Lucas
    Gazzinelli, Maria Flavia
    Gazzinelli, Andrea
    Soares, Amanda Nathale
    CADERNOS DE SAUDE PUBLICA, 2014, 30 (06): : 1305 - 1314
  • [14] Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
    Radanovic, Igor
    Klarenbeek, Naomi
    Rissmann, Robert
    Groeneveld, Geert Jan
    van Brummelen, Emilie M. J.
    Moerland, Matthijs
    Bosch, Jacobus J.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [15] The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research
    Wang, Zejuan
    Chen, Gang
    Liu, Xiaona
    Liu, Chen
    Song, Qingkun
    Wang, Jin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (04) : 557 - 568
  • [16] Risk and Emotion Among Healthy Volunteers in Clinical Trials
    Cottingham, Marci D.
    Fisher, Jill A.
    SOCIAL PSYCHOLOGY QUARTERLY, 2016, 79 (03) : 222 - 242
  • [17] Informal professionalization of healthy participants in phase I clinical trials in Russia
    Zvonareva, Olga
    Pimenov, Igor
    Kutishenko, Natalia
    Mareev, Igor
    Martsevich, Sergey
    Kulikov, Evgeny
    CLINICAL TRIALS, 2019, 16 (06) : 563 - 570
  • [18] Disadvantaged, outnumbered, and discouraged: women's experiences as healthy volunteers in US Phase I trials
    Jain, Nupur
    Cottingham, Marci D.
    Fisher, Jill A.
    CRITICAL PUBLIC HEALTH, 2020, 30 (02) : 141 - 152
  • [19] Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials
    Weinfurt, KP
    DePuy, V
    Castel, LD
    Sulmasy, DP
    Schulman, KA
    Meropol, NJ
    CANCER, 2005, 103 (01) : 140 - 147
  • [20] Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in phase I clinical trials
    Sibille, M
    Deigat, N
    Durieu, I
    Guillaumont, M
    Morel, D
    Bienvenu, J
    Massignon, D
    Durand, DV
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (01) : 13 - 19